Cannabidiol (CBD) is the main cannabinoid naturally occurring in hemp. It has recently attracted the attention of the scientific community because of its numerous pharmacological activities. However, its legal status changes depending on whether it is chemically synthesized or extracted from the plant: extracted CBD is a scheduled controlled substance, whereas synthetic CBD is not under control. In Europe, extracted CBD is excluded from the cosmetic ingredients of the CosIng database. Given the confusion surrounding these different forms of CBD, there is an urgent need for clarity to shed light from both a regulatory and a chemical point of view. The impurity profiles of synthetic and natural CBD are different and could currently represent the only means to distinguish the origin of this substance.

Is cannabidiol a scheduled controlled substance? Origin makes the difference / Citti, C.; Linciano, P.; Cannazza, G.. - In: DRUG DISCOVERY TODAY. - ISSN 1359-6446. - (2020), pp. 1-5. [10.1016/j.drudis.2020.02.001]

Is cannabidiol a scheduled controlled substance? Origin makes the difference

Citti C.;Linciano P.;Cannazza G.
2020

Abstract

Cannabidiol (CBD) is the main cannabinoid naturally occurring in hemp. It has recently attracted the attention of the scientific community because of its numerous pharmacological activities. However, its legal status changes depending on whether it is chemically synthesized or extracted from the plant: extracted CBD is a scheduled controlled substance, whereas synthetic CBD is not under control. In Europe, extracted CBD is excluded from the cosmetic ingredients of the CosIng database. Given the confusion surrounding these different forms of CBD, there is an urgent need for clarity to shed light from both a regulatory and a chemical point of view. The impurity profiles of synthetic and natural CBD are different and could currently represent the only means to distinguish the origin of this substance.
2020
13-feb-2020
1
5
Is cannabidiol a scheduled controlled substance? Origin makes the difference / Citti, C.; Linciano, P.; Cannazza, G.. - In: DRUG DISCOVERY TODAY. - ISSN 1359-6446. - (2020), pp. 1-5. [10.1016/j.drudis.2020.02.001]
Citti, C.; Linciano, P.; Cannazza, G.
File in questo prodotto:
File Dimensione Formato  
Is cannabidiol a scheduled controlled.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 431.46 kB
Formato Adobe PDF
431.46 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1199099
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact